Europe Immunotherapy Drugs Market, by drug type (monoclonal antibodies, interferons, interleukins, vaccines and checkpoint inhibitors), by application (Blood Cancer, Cervical Cancer, Breast Cancer, Glioblastoma, Lung Cancer, Gastric Cancer, Prostate Cancer and Melanoma) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Europe Immunotherapy Drugs Market, by drug type (monoclonal antibodies, interferons, interleukins, vaccines and checkpoint inhibitors), by application (Blood Cancer, Cervical Cancer, Breast Cancer, Glioblastoma, Lung Cancer, Gastric Cancer, Prostate Cancer and Melanoma) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 1158 | Pages: 134 | November 2016 | Region: Europe


Europe Immunotherapy Drugs Market is currently worth USD 15.05 billion in 2016 and is forecasted to reach USD 24.9 billion by 2021 having a growth rate (CAGR) of 10.6%. The usage of immunotherapy drugs is on the rise with the increases cases of cancer and autoimmune diseases. And also, owing to its lesser side effects, the market is likely to propel in the forecast period.

Immunotherapy is a way of treating cancer by enhancing the innate power of the immune system. The treatment involves using the individual’s own immune system to fight cancer cells. It either stimulates the function of each particular component of the immune system or act against the signals caused by the cancer cells suppressing the responses by the immune system. These properties of the immunotherapy drugs to be able to aid the immune system fight against the abnormal cells makes them being successfully used against the diseases like infection, cancer, autoimmune and respiratory disorders.

Rising incidences of cancer and other autoimmune diseases has led to innovations in the development of drugs with the help of technological advancements. The others factors responsible for the growth of the market includes emergence of biosimilars, higher efficacy than the common drugs with lower side effects and reduction in the overall time of developing and testing of new drugs. However, the market is restrained by the higher cost related to the treatment and lower accessibility.

Europe Immunotherapy Market is classified based on the drug type and its application. By type of drug, the market is segmented as interferons, monoclonal antibodies, vaccines, interleukins and checkpoint inhibitors. Based on application of the drug, the market is classified as blood cancer, Glioblastoma, Gastric Cancer, Lung Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer and Melanoma. By geography, the market in Europe is categorised as United Kingdom, Germany, France, Italy and Spain.

Some the major companies in the Immunotherapy Drugs industry include Eli Lilly, Bristol Myers Squibb, Roche, Novartis, Amgen, Merck, AstraZeneca, Celgene, Seattle Genetics and GlaxoSmithKline PLC.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Drug Type                             

                                5.1.1 Monoclonal Antibodies     

                                5.1.2 Interferons             

                                5.1.3 Interleukins            

                                5.1.4 Vaccines  

                                5.1.5 Checkpoint Inhibitors         

                5.2 By Application                           

                                5.2.1 Blood Cancer         

                                5.2.2 Cervical Cancer     

                                5.2.3 Breast Cancer        

                                5.2.4 Glioblastoma         

                                5.2.5 Lung Cancer           

                                5.2.6 Gastric Cancer       

                                5.2.7 Prostate Cancer    

                                5.2.8 Melanoma              

6. Geographical Analysis                                              

                6.1 Introduction                              

                6.2 U.K                

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7. Pipeline Product Analysis                                        

                7.1 Overview                                    

                7.2 Pipeline Development Landscape                                     

                7.3 Molecular Targets in the Pipeline                                     

                7.4 Clinical Trials                              

                                7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target       

                                7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target                 

                                7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target.               

8. Strategic Analysis                                       

                8.1 PESTLE analysis                         

                                8.1.1 Political     

                                8.1.2 Economic 

                                8.1.3 Social         

                                8.1.4 Technological         

                                8.1.5 Legal          

                                8.1.6 Environmental      

                8.2 Porter’s Five analysis                              

                                8.2.1 Bargaining Power of Suppliers        

                                8.2.2 Bargaining Power of Consumers    

                                8.2.3 Threat of New Entrants     

                                8.2.4 Threat of Substitute Products and Services

                                8.2.5 Competitive Rivalry within the Industry      

9. Market Leaders' Analysis                                        

                9.1 Eli Lilly                           

                                9.1.1 Overview

                                9.1.2 Product Analysis   

                                9.1.3 Financial analysis  

                                9.1.4 Recent Developments       

                                9.1.5 SWOT analysis       

                                9.1.6 Analyst View          

                9.2 Merck                           

                9.3 Roche                           

                9.4 Amgen                         

                9.5 Novartis                       

                9.6 Celgene                       

                9.7 AstraZeneca               

                9.8 Bristol Myers Squibb                              

                9.9 GlaxoSmithKline PLC                              

                9.10 Seattle Genetics                    

10. Competitive Landscape                                         

                10.1 Market share analysis                          

                10.2 Merger and Acquisition Analysis                     

                10.3 Agreements, collaborations and Joint Ventures                       

                10.4 New Product Launches                       

11. Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Europe Immunotherapy Drugs Market By Region, From 2016-2021 (USD Billion)
  2. Europe Immunotherapy Drugs Market By Drug Type, From 2016-2021 (USD Billion)
  3. Europe Monoclonal Antibodies Market By Region, From 2016-2021 (USD Billion)
  4. Europe Interferons Market By Region, From 2016-2021 (USD Billion)
  5. Europe Interleukins Market By Region, From 2016-2021 (USD Billion)
  6. Europe Vaccines Market By Region, From 2016-2021 (USD Billion)
  7. Europe Checkpoint Inhibitors Market By Region, From 2016-2021 (USD Billion)
  8. Europe Immunotherapy Drugs Market By Application, From 2016-2021 (USD Billion)
  9. Europe Blood Cancer Market By Region, From 2016-2021 (USD Billion)
  10. Europe Cervical Cancer Market By Region, From 2016-2021 (USD Billion)
  11. Europe Breast Cancer Market By Region, From 2016-2021 (USD Billion)
  12. Europe Glioblastoma Market By Region, From 2016-2021 (USD Billion)
  13. Europe Lung Cancer Market By Region, From 2016-2021 (USD Billion)
  14. Europe Gastric Cancer Market By Region, From 2016-2021 (USD Billion)
  15. Europe Prostate Cancer Market By Region, From 2016-2021 (USD Billion)
  16. Europe Melanoma Market By Region, From 2016-2021 (USD Billion)
  17. U.K Immunotherapy Drugs Market By Drug Type, From 2016-2021 (USD Billion)
  18. U.K Immunotherapy Drugs Market By Application, From 2016-2021 (USD Billion)
  19. Spain Immunotherapy Drugs Market By Drug Type, From 2016-2021 (USD Billion)
  20. Spain Immunotherapy Drugs Market By Application, From 2016-2021 (USD Billion)
  21. Germany Immunotherapy Drugs Market By Drug Type, From 2016-2021 (USD Billion)
  22. Germany Immunotherapy Drugs Market By Application, From 2016-2021 (USD Billion)
  23. Italy Immunotherapy Drugs Market By Drug Type, From 2016-2021 (USD Billion)
  24. Italy Immunotherapy Drugs Market By Application, From 2016-2021 (USD Billion)
  25. France Immunotherapy Drugs Market By Drug Type, From 2016-2021 (USD Billion)
  26. France Immunotherapy Drugs Market By Application, From 2016-2021 (USD Billion)
Middle East And Africa Surface Plasmon Resonance Market By Product (Imaging System, Sensor System And Reagent) By Application (Drug Discovery, Material Sciences, Biosensor) – Industry Analysis, Size, Share, Growth...
Latin America Surface Plasmon Resonance Market By Product (Imaging System, Sensor System And Reagent) By Application (Drug Discovery, Material Sciences, Biosensor) –Latin America Industry Analysis, Size, Share, Gr...
Asia Pacific Surface Plasmon Resonance Market By Product (Imaging System, Sensor System And Reagent) By Application (Drug Discovery, Material Sciences, Biosensor) – Industry Analysis, Size, Share, Growth, Trends, ...
Europe Surface Plasmon Resonance Market By Product (Imaging System, Sensor System And Reagent) By Application (Drug Discovery, Material Sciences, Biosensor) – Industry Analysis, Size, Share, Growth, Trends, And Fo...
North America Surface Plasmon Resonance Market By Product (Imaging System, Sensor System And Reagent) By Application (Drug Discovery, Material Sciences, Biosensor) – Industry Analysis, Size, Share, Growth, Trends,...
Surface Plasmon Resonance Market By Product (Sensor System And Reagent , Imaging System) By Application (Material Sciences, Drug Discovery, Biosensor), And By Region - Global Industry Analysis, Size, Share, Growth, ...
Middle East And Africa Blood Brain Barrier Technologies Market By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)...
Latin America Blood Brain Barrier Technologies Market By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)...
Asia Pacific Blood Brain Barrier Technologies Market By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)...
Europe Blood Brain Barrier Technologies Market By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)...
North America Blood Brain Barrier Technologies Market By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)...
Blood Brain Barrier Technologies Market By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.